SCHEMBL259152

SCHEMBL259152

c1ccc(-c2ccc3c(-c4ccc5ccccc5c4)c4ccccc4c(-c4ccc5ccccc5c4)c3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.50
ESR2 Q92731 6/20 0.50
HSD17B1 P14061 2/20 0.47
HSD17B2 P37059 2/20 0.47
CYP17A1 P05093 1/20 0.44
CYP19A1 P11511 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
ALOX5 P09917 2/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
GPR84 Q9NQS5 2/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2B6 P20813 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29375861 1.00 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL27367720 0.98 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL29330637 0.96 HSD17B1 (0.49) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL29295264 0.96 ESR1 (0.47) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL3460383 0.96 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL28538557 0.94 ESR1 (0.49) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL19720301 0.94 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL21238074 0.94 ESR1 (0.52) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL269358 0.94 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2CYP17A1
SCHEMBL2964464 0.94 ESR1 (0.50) ESR1ESR2HSD17B1HSD17B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2026-03-19 US claimed
US-20240298524-A1 N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant NOVALED GMBH (DE) 2024-09-05 US claimed
US-20240237385-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE LG DISPLAY CO., LTD. (KR) 2024-07-11 US claimed
US-20240224570-A1 ORGANIC LIGHT EMITTING DIODES AND ORGANIC LIGHT EMITTING DEVICES LG DISPLAY CO., LTD. (KR) 2024-07-04 US claimed
US-20240215288-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE LG DISPLAY CO., LTD. (KR) 2024-06-27 US claimed
EP-4391767-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE LG Display Co., Ltd. (KR) 2024-06-26 EP claimed
US-11849598-B2 Organic light-emitting component having a light-emitting layer as part of a charge generation layer PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2023-12-19 US claimed
US-11355721-B2 Organic light emitting device comprising polar matrix, metal dopant and silver cathode NOVALED GMBH (DE) 2022-06-07 US claimed
US-20220085338-A1 ORGANIC LIGHT-EMITTING COMPONENT HAVING A LIGHT-EMITTING LAYER AS PART OF A CHARGE GENERATION LAYER PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2022-03-17 US claimed
US-11211590-B2 Organic light-emitting component having a light-emitting layer as part of a charge generation layer PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2021-12-28 US claimed
WO-2011039323-A2 ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2011-04-07 WO claimed
EP-2286474-A2 METHOD OF MAKING AN OLED Merck Patent GmbH (DE) 2011-02-23 EP claimed
US-20100084647-A1 ELECTROLUMINESCENT DEVICES INCLUDING ORGANIC EIL LAYER GLOBAL OLED TECHNOLOGY LLC 2010-04-08 US claimed
WO-2009149860-A2 METHOD OF MAKING AN OLED MERCK PATENT GMBH (DE) 2009-12-17 WO claimed
EP-2011178-A2 ELECTROLUMINESCENT DEVICES INCLUDING ORGANIC ELECTRON INJECTION LAYER EASTMAN KODAK COMPANY (US) 2009-01-07 EP claimed
WO-2007127063-A2 ELECTROLUMINESCENT DEVICES INCLUDING ORGANIC EIL LAYER EASTMAN KODAK COMPANY (US) 2007-11-08 WO claimed
US-20070252516-A1 Electroluminescent devices including organic EIL layer EASTMAN KODAK COMPANY 2007-11-01 US claimed
WO-2006047075-A1 ORGANIC LIGHT-EMITTING DEVICES WITH IMPROVED PERFORMANCE EASTMAN KODAK COMPANY (US) 2006-05-04 WO claimed
US-20060088730-A1 Organic light-emitting devices with improved performance EASTMAN KODAK COMPANY 2006-04-27 US claimed
US-20060088729-A1 White organic light-emitting devices with improved performance EASTMAN KODAK COMPANY 2006-04-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT FLNA, FLNB, CDH1 ESR1 248/4885ESR2 700/4885HSD17B1 3269/4885
US-20240298524-A1 N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant NNMT, PNN, PNMT ESR1 1805/4885ESR2 2491/4885HSD17B1 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.